{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:35:05Z","timestamp":1789799705072,"version":"4.0.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Karius Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunocompromised patients are at high risk of pneumonia, with associated poor outcomes. Rapid microbiologic diagnosis is crucial, yet diagnostic yields vary widely. We evaluated the variability in diagnostic yield of usual care testing and plasma microbial cell-free DNA (mcfDNA) sequencing in the prospective observational Pneumonia in the Immunocompromised\u2014Use of the Karius Test for the Detection of Undiagnosed Pathogens (PICKUP) study, specifically focusing on timing of testing relative to the onset of pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this exploratory analysis, patient characteristics, variability in diagnostic yield, and the timing of bronchoscopy and mcfDNA sequencing from date of first abnormal imaging associated with suspected pneumonia were evaluated across enrolling sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 222 patients from 10 enrolling sites were analyzed. Usual care diagnostic yield varied across sites (range, 7.7%\u201357.7%). Patient characteristics did not differ between sites, and median time from abnormal imaging to bronchoscopy was not different across sites (3 days [IQR, 3]). Diagnostic yield of bronchoscopy was significantly higher when performed \u22643 days (early) from abnormal imaging (38.5% [52\/135]) versus &amp;gt;3 days (delayed) (21.8% [19\/87]) (difference, 16.7% [95% CI, 2.5%\u201328.3%]; P = .009). Adding mcfDNA sequencing to usual care testing increased overall diagnostic yield by 7.9% for patients undergoing early bronchoscopy, and by 16.3% for delayed bronchoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early bronchoscopy enhances diagnostic yield in immunocompromised patients with suspected pneumonia. Irrespective of timing, plasma mcfDNA sequencing increases overall diagnostic yield in this clinical scenario. These findings underscore the importance of prompt diagnostic strategies in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag361","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:36:08Z","timestamp":1781627768000},"source":"Crossref","is-referenced-by-count":1,"title":["Timing of Bronchoscopy and Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Host Pneumonia"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3149-597X","authenticated-orcid":false,"given":"Ahmad","family":"Mourad","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-5482","authenticated-orcid":false,"given":"Daniel S","family":"Lupu","sequence":"additional","affiliation":[{"name":"Karius Inc , Redwood City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Richey","sequence":"additional","affiliation":[{"name":"Karius Inc , Redwood City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2083-2196","authenticated-orcid":false,"given":"Paul","family":"Steven","sequence":"additional","affiliation":[{"name":"North American Science Associates Ltd , Selby ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance G","family":"Fowler","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Perkins","sequence":"additional","affiliation":[{"name":"Karius Inc , Redwood City, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7745-9010","authenticated-orcid":false,"given":"Thomas L","family":"Holland","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]},{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-9456","authenticated-orcid":false,"given":"Stephen P","family":"Bergin","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute , Durham, North Carolina ,","place":["USA"]},{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine , Durham, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2026061808512601300_ofag361-B1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10096-024-04883-y","article-title":"Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation","volume":"43","author":"Seybold","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026061808512601300_ofag361-B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"2026061808512601300_ofag361-B3","doi-asserted-by":"crossref","first-page":"ofad616","DOI":"10.1093\/ofid\/ofad616","article-title":"A systematic literature review to identify diagnostic gaps in managing immunocompromised patients with cancer and suspected infection","volume":"11","author":"Hill","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026061808512601300_ofag361-B4","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026061808512601300_ofag361-B5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1445-5994.2011.02643.x","article-title":"Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders","volume":"42","author":"Seneviratna","year":"2012","journal-title":"Intern Med J"},{"key":"2026061808512601300_ofag361-B6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00277-014-2172-3","article-title":"Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates","volume":"94","author":"Kim","year":"2015","journal-title":"Ann Hematol"},{"key":"2026061808512601300_ofag361-B7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.CCM.0000295590.33145.C4","article-title":"Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data","volume":"36","author":"Azoulay","year":"2008","journal-title":"Crit Care Med"},{"key":"2026061808512601300_ofag361-B8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-007-0391-6","article-title":"Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates","volume":"87","author":"Hummel","year":"2008","journal-title":"Ann Hematol"},{"key":"2026061808512601300_ofag361-B9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/bmt.2014.151","article-title":"Pulmonary complications in hematopoietic SCT: a prospective study","volume":"49","author":"Lucena","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"2026061808512601300_ofag361-B10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12890-020-01283-8","article-title":"Safety of bronchoscopy in patients with malignant hematologic disorders","volume":"20","author":"Uruga","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2026061808512601300_ofag361-B11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/jiad255","article-title":"Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant","volume":"229","author":"Heldman","year":"2024","journal-title":"J Infect Dis"},{"key":"2026061808512601300_ofag361-B12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/cid\/ciaf170","article-title":"Plasma microbial cell-free DNA metagenomic sequencing for diagnosis of invasive fungal diseases among high risk outpatient and inpatient immunocompromised hosts","volume":"81","author":"Sim","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026061808512601300_ofag361-B13","doi-asserted-by":"crossref","first-page":"ofae252","DOI":"10.1093\/ofid\/ofae252","article-title":"Diagnostic value of microbial cell-free DNA sequencing for suspected invasive fungal infections: a retrospective multicenter cohort study","volume":"11","author":"Huygens","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026061808512601300_ofag361-B14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/cid\/ciad599","article-title":"Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study","volume":"78","author":"Bergin","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026061808512601300_ofag361-B15","doi-asserted-by":"crossref","first-page":"1106859","DOI":"10.3389\/fcimb.2023.1106859","article-title":"Clinical values of metagenomic next-generation sequencing in patients with severe pneumonia: a systematic review and meta-analysis","volume":"13","author":"Lv","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2026061808512601300_ofag361-B16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"2026061808512601300_ofag361-B17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1513\/AnnalsATS.202212-1019ST","article-title":"Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society workshop report","volume":"20","author":"Cheng","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026061808512601300_ofag361-B18","volume-title":"Analytical and clinical validation of microbial cell-free DNA sequencing of bronchoalveolar lavage fluid","author":"Blauwkamp","year":"2025"},{"key":"2026061808512601300_ofag361-B19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/cid\/ciab742","article-title":"Microbial cell-free DNA identifies etiology of bloodstream infections, persists longer than conventional blood cultures, and its duration of detection is associated with metastatic infection in patients with Staphylococcus aureus and gram-negative bacteremia","volume":"74","author":"Eichenberger","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026061808512601300_ofag361-B20","doi-asserted-by":"crossref","first-page":"106395","DOI":"10.1016\/j.jinf.2024.106395","article-title":"Diagnostic performance of metagenomic next-generation sequencing among hematological malignancy patients with bloodstream infections after antimicrobial therapy","volume":"90","author":"Xu","year":"2025","journal-title":"J Infect"},{"key":"2026061808512601300_ofag361-B21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12879-022-07357-8","article-title":"Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study","volume":"22","author":"Shishido","year":"2022","journal-title":"BMC Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag361\/68548375\/ofag361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag361\/68548375\/ofag361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:51:37Z","timestamp":1781787097000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag361\/8711035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag361","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"ofag361"}}